Drug design using comparative molecular surface analysis

Expert Opinion on Drug Discovery

Volumn 1, Issue 7, 2006, Pages 693-707

  Polanski, Jaroslaw ^a  

^a UNIVERSITY OF SILESIA   (Poland)

Author keywords

3D QSAR; CBG steroids; CoMSA; molecular shape analysis

Indexed keywords

EID: 34547711605     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.1.7.693     Document Type: Review

References (83)

1. POLANSKI J: Molecular shape analysis. In:Handbook of chemoinformatics from data to knowledge. Gasteiger J (Ed), Wiley-VCH Weinheim (2003):302-319.
2. MEZEY PG: Shape in chemistry an introduction to molecular shape and topology, VCH, New York, USA (1993).
3. KOLB HC, FINN MG, SHARPLESS KB: Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. (2001) 40(11):2004-2021.
4. BORMAN S: Drugs by design, Chem. Eng. News (2005) 83(48):28-30.
5. BANNWARTH W, FELDER E (Eds): Combinatorial chemistry: a practical approach. In:Methods and Principles in Medicinal Chemistry Vol 9. Mannhold R, Kubinyi H, Timmerman H. (Eds.), Wiley-VCH, Weinheim (2000).
6. BORMAN S: Improving efficiency. Chem. Eng. News. (2006) 84(25):56-78.
7. LIPINSKI C, HOPKINS A: Navigating chemical space for biology and medicine. Nature (2004) 432(7019):855-861.
8. WOLD S, SJOSTROM M, ERIKSSON L: Partial least square projections to latent structures (PLS) in chemistry. In:Encyclopedia of Computational Chemistry. Schleyer PR (Eds), Wiley, Chichester (1999):2006-2021.
9. POLANSKI J, GIELECIAK R, BAK A: Probability issues in molecular design: predictive and modeling ability in 3D-QSAR schemes. Combin. Chem. High Throughput Screen. (2004) 7(8):793-807.
10. COATS E: The CoMFA steroids as a benchmark data set for development of 3D QSAR methods. Persp. Drug Discov. Design (1998) 12/13/14:199-213.
11. BOYD DB: Successes of Computer-Assisted Molecular Design. In:reviews in computational chemistry (Volume 1). Lipkowitz KB, Boyd DB (Eds.), VCH Publishers, New York (1990):355-371.
12. POLANSKI J, WALCZAK B: The comparative molecular surface analysis (CoMSA): A novel tool for molecular design. Comput. Chem. (2000) 24(5):615-625.
13. TODESCHINI R, CONSONNI V: Handbook of Molecular Descriptors. In:Methods and Principles in Medicinal Chemistry (Volume 11) Mannhold R, Kubinyi H, Timmerman H. (Eds), Wiley-VCH, Weinheim (2000).
14. ALLINGER NL: Pharmacology and the Future of Men, vol. 5, Proc. 5-th Int. Congr. Pharmacol. (1972) 57.
15. JAIN A, KOILE K, CHAMPAN D: Compass: predicting biological activities from molecular surface properties. Performance comparison on a steroid benchmark. J. Med. Chem (1994) 37(15):2315-2327.
16. IVANCIUC O, IVANCIUC T, CABROL-BASS D: Comparative receptor surface analysis (CoRSA) model for calcium channel antagonists. SAR QSAR Environ. Res. (2001) 12(1-2):93-111.
17. BLANEY F, PHIPPEN R, WATT M: Molecular surface comparison: application to drug design. J. Mol. Graphics (1993) 11(2):98-105.
18. DANZIGER DJ, DEAN PM: The search for functional correspondence in molecular structure between two dissimilar molecules. J. Theor. Biol. (1985) 116(2):215-224.
19. NAMASIVYAN S, DEAN PM: Statistical methods for surface pattern matching between dissimilar molecules. J. Mol. Graphics (1986) 4(1):46-50.
20. CHAU PL, DEAN PM: Molecular recognition: 3D surface structure comparison by gnomic projection. J. Mol. Graphics (1987) 5(2):97-100.
21. CHAU PL, DEAN PM: Molecular recognition: optimized searching through rotational 3-space. J. Mol. Graphics (1987) 5(3):152-158.
22. BLANEY FE, EDGE C, PHIPPEN RW: Molecular surface comparison. 2. Similarity of electrostatic vector fields in drug design. J. Mol. Graphics (1995) 13(3):165-174.
23. ZAUHAR RJ, WELSH WJ: Application of the shape signatures approach to ligandand receptor-based drug design, 200nd ACS Natl. Meet. Washington DC (2000) COMP70.
24. LAVINE BK, DAVIDSON CE, BRENEMAN C, KATT W: Electronic van der Waals surface property descriptors and genetic algorithms for developing structure-activity correlations in olfactory databases. J Chem. Inform. Comp. Sci. (2003) 43(6):1890-1905.
25. BRENEMAN CM, SUNDLING CM, SUKUMAR N, SHEN LL, KATT WP, EMBRECHTS MJ: New developments in PEST shape/property hybrid descriptors. J. Comp-Aided Mol. Des. (2003) 17(2):231-240.
26. HEIDEN W, BRICKMANN J: Segmentation of protein surfaces using fuzzy logic. J. Mol. Graphics (1994) 12(2):106-115.
27. HAIGH JA, PICKUP BT, GRANT JA, NICHOLLS A: Small molecule shape-fingerprints. J. Chem. Inf. Model (2005) 45(3):673-784.
28. DIETTERICH TG, LATHROP RH, LOZANOPEREZ T: Solving the multiple instance problem with axis-parallel rectangles. Artif. Intell. (1997) 89(1-2):31-71.
29. HOFBAUER C, LOHNINGER H, ASZÓDI A: Surfcomp: a novel graph-based approach to molecular surface comparison. J. Chem. Inform. Comp. Sci. (2004) 44(3):837-847.
30. MASEK BB: Molecular Surface Comparisons. In:Molecular Similarity in Drug Design. Dean PM (Ed), Blackie Academic and Professional, Glasgow (1995) 321-328.
31. ARTECA GA: Molecular shape descriptors. In:Reviews in Computational Chemistry (Volume 9). Lipkowitz KB, Boyd DB (Eds), VCH Publishers, New York, Weinheim. (1996):191-253.
32. ZUPAN J, GASTEIGER J: Neural Networks in Chemistry and Drug Design. Second Edition. Wiley-VCH, Weinheim (1999).
33. KOHONEN T: Self-organized formation of topologically correct feature maps. Biol. Cybern. (1982) 43(1):59-69.
34. GASTEIGER J, ZUPAN J: Neural networks in chemistry. Angew. Chem. Int. Ed. Engl. (1993) 32(4):502-527.
35. GASTEIGER J, LI X, RUDOLPH C, SADOWSKI J, ZUPAN J: Representation of molecular electrostatic potentials by topological feature maps. J. Am. Chem. Soc. (1994) 116(11):4608-4620.
36. GASTEIGER J, LI X: Mapping the electrostatic potential of muscarinic and nicotinic agonists with artificial neural networks. Angew. Chem. Int. Ed. Engl. (1994) 33(6):643-646.
37. ANZALI S, BARNICKEL G, KRUG M et al.: The comparison of geometric and electronic properties of molecular surfaces by neural networks: application to the analysis of corticosteroid binding globulin activity of steroids. J. Comput.-Aided Mol. Design (1996) 10(6):521-534.
38. MEDERSKI WWKR, DORSCH D, OSSWALD M et al.: Endothelin antagonists: discovery of EMD 122946, a highly potent and orally-active ETA selective antagonist. Bioorg. Med. Chem. 8(13):1771-1776.
39. ANZALI S, MEDERSKI WWKR, OSSWALD M, DORSCH D: 1. Endothelin antagonists: search for surrogates of methylendioxyphenyl by means of a Kohonen neural network. Bioorg. Med. Chem. (1998) 8(1):11-16.
40. POLANSKI J, GASTEIGER J, JARZEMBEK K: Self-organizing neural networks for screening and development of novel artificial sweetener candidates. Comb. Chem. High Throughput Screen. (1998) 3(6):481-495.
41. BARLOW TWJ: Self-organizing maps and molecular similarity. J. Mol. Graph (1995) 13(1):24-27.
42. POLANSKI J, GASTEIGER J: The comparison of molecular surface by assembly of self-organizing neural network. Proceedings of the III-th International Conference Computers in Chemistry 94, Technical University of Wroclaw, Wroclaw, Poland (1994) 88.
43. POLANSKI J, GASTEIGER J, WAGENER M, SADOWSKI J: The comparison of molecular surfaces by neural networks and its application to quantitative structure-activity studies. Quant. Struct. Act. Relat. (1998) 17(1):27-36.
44. ANZALI S, GASTEIGER J, HOLZGRABE U I: The use of self-organizing neural networks in drug design, Perspect. Drug Discov. (1998) 9-11:273-299.
45. POLANSKI J, WALCZAK B: The comparative molecular surface analysis (CoMSA): a novel tool for molecular design. Comput. Chem. (2000) 24(5):615-625.
46. POLANSKI J, GIELECIAK R, MAGDZIARZ T, BAK A: The grid formalism for the comparative molecular surface analysis: application to the CoMFA benchmark steroids, azo dyes and HEPT derivatives. J. Chem. Inf. Comput. Sci. (2004) 44(4):1423-1435.
47. POLANSKI J, BAK A, GIELECIAK R, MAGDZIARZ T: Self-organizing neural network for modeling robust 3D and 4D QSAR: application to dihydrofolate reductase inhibitors. Molecules (2004) 9(12):1148-1159.
48. POLANSKI J, GIELECIAK R, BAK A, JARZEMBEK K, WYSZOMIRSKI M: A comparative molecular surface analysis (CoMSA). A novel efficient technique for drug design. Acta Pol. Pharm. (2002) 59:459-461.
49. POLANSKI J, GIELECIAK R, BAK A: The comparative molecular surface analysis (CoMSA) - a nongrid 3D QSAR method by a coupled neural network and PLS system: predicting pKa values of benzoic and acetic acid analogues. J. Chem. Inf. Comput. Sci. (2002) 42(2):184-191.
50. POLANSKI J, GIELECIAK R: The comparative molecular surface analysis (CoMSA) with modified uninformative variable elimination PLS (UVE-PLS) method: Application to the steroids binding the aromatase enzyme. J. Chem. Inf. Comput. Sci. (2003) 43(2):656-666.
51. POLANSKI J: Self-organizing neural networks for pharmacophore mapping. Adv. Drug Deliv. Rev. (2003) 55(9):1149-1162.
52. GIELECIAK R, MAGDZIARZ T, BAK A, POLANSKI J: Modeling robust QSAR 1: Coding molecles in 3D QSAR - from a point to surface sectors and molecular volumes. J. Chem. Inf. Model. (2005) 45(5):1447-1455.
53. POLANSKI J, BAK A: Modeling steric and electronic effects in 3D- and 4D-QSAR schemes: predicting benzoic pKa values and steroic CBG binding affinities. J. Chem. Inf. Comput. Sci. (2003) 43(6):2081-2092.
54. POLANSKI J: The non-grid technique for modeling 3D QSAR using self-organizing neural network (SOM) and PLS analysis: application to steroids and colchicinoids. SAR QSAR Environ. Res. (2000) 11(3-4):245-261.
55. POLANSKI J: Self-organizing neural network for modeling 3D QSAR of colchicinoids. Acta Biochim. Pol. (2000) 47(1):37-45.
56. POLANSKI J, GIELECIAK R, WYSZOMIRSKI M: Mapping dye pharmacophores by the comparative molecular surface analysis (CoMSA): application to the heterocyclic monoazo dyes. Dyes Pigments (2004) 62(1):61-76.
57. HASEGAWA K, MORIKAMI K, SHIRATORI Y, OHTSUKA T, AOKI Y, SHIMMA N: 3D-QSAR study of antifungal N-myristoyltra transferase inhibitors by comparative molecular surface analysis. Chemom. Intell. Lab. Syst. (2003) 69(1-2):51-59
58. HASEGAWA K, MATSUOKA S, ARAKAWA M, FUNATSU K: New molecular surface-based 3D-QSAR metod using Kohonen neural network and 3-way PLS. Comput. Chem. (2002) 26(6):583-589.
59. HOPFINGER A, WANG S, TOKARSKI J et al.: Construction of 3D-QSAR models using the 4D-QSAR analysis formalism. J. Am. Chem. Soc. (1997) 119(43):10509-10524.
60. CRAMER R III, PATTERSON D, BUNCE J: Comparative molecular field analysis (CoMFA). J. Am. Chem. Soc. (1998) 110(18):5959-5967.
61. WAGENER M, SADOWSKI J, GASTEIGER J: Autocorrelation of molecular surface properties for modeling corticosteroid binding globulin and cytosolic Ah receptor activity by neural networks. J. Am. Chem. Soc. (1995) 117(29):769-775.
62. CHEN JC-H, KRUCINSKI J, MIERCKE LJW et al.: Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding. Proc. Natl. Acad. Sci. USA (2000) 97(15):233-238.
63. MEKOUAR K, MOUSCADET JF, DESMAËLE D et al.: Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. J. Med. Chem. (1998) 41(15):2846-2857.
64. ZOUHIRI F, MOUSCADET JF, MEKOUAR K et al.: Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1-integrase and replication of HIV-1 in cell culture. J. Med. Chem. (2000) 43(8):1533-1540.
65. OUALI M, LABOULAIS C, LEH H et al.: Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives. J. Med. Chem. (2000) 43(10):1949-1957.
66. OUALI M, LABOULAIS C, LEH H et al.: Tautomers of styrylquinoline derivatives containing a methoxy substituent: computation of their population in aqueous solution and their interaction with RSV integrase catalytic core. Acta Bioch. Pol. (2000) 47(1):11-22.
67. POLANSKI J, ZOUHIRI F, JEANSON L: Use of the Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines. J. Med. Chem. (2002) 45(21):4647-4654.
68. POLANSKI J, NIEDBALA H, MUSIOL R et al.: 5-Hydroxy-6-quinaldic acid as a novel molecular scaffold for hiv-1 Integrase Inhibitors. Lett. Drug Des. Discov. (2006) 3(3):175-178.
69. CENTNER V, MASSART DL, DE NOORD OE, DE JONG S, VANDEGINSTE BMV, STERNA C: Elimination of uninformative variables for multivariate calibration. Anal. Chem. (1996) 68(21):3851-3858.
70. MAGDZIARZ T, LOZOWICKA B, GIELECIAK R et al.: 3D QSAR study of hypolipidemic asarones by comparative molecular surface analysis. Bioorg. Med. Chem. (2006) 14(5):1630-1643.
71. HASEGAWA K, ARAKAWA M, FUNATSU K: Novel computational approaches in QSAR and molecular design based on multi-way PLS and NN. Curr. Comput.-Aided Drug Des. (2005) 1(2):129-145.
72. KIM KH, MARTIN YC: Direct prediction of linear free energy substituent effects from 3D structures using comparative molecular field analysis. 1. Electronic effects of substituted benzoic acids. J. Org. Chem. (1991) 56(8):2723-2729.
73. MARTIN YC, LIN TC, HETTI CH, DELAZZER J: PLS Analysis of distance matrices to detect nonlinear relationships between biological potency and molecular properties. J. Med. Chem. (1995) 38(16):3009-3015.
74. GIELECIAK R, POLANSKI J: Modeling robust QSAR 2: iterative variable elimination schemes for comsa: application for modeling benzoic acid pKa values. J. Chem. Inf. Model. (In Press).
75. CHONG IG, JUN CH: Performance of some variable selection methods when multicollinearity is present. Chemom. Intell. Lab. Syst. (2005) 78(1-2):103-112.
76. POLANSKI J, GIELECIAK R, WYSZOMIRSKI M: Comparative molecular surface analysis (CoMSA) for modeling dye-fibre affinities of the azo and antraquinone dyes. J. Chem. Inf. Comput. Sci. (2003) 43(6):1754-1762.
77. FABIAN WMF, TIMOFEI S, KURUNCZI L: Comparative molecular field analysis (CoMFA), semiempirical (AM1) molecular orbital and multiconformational minimal steric difference (mtd) calculation of anthraquinone dye-fibre affinities. J. Mol. Struct. THEOCHEM (1995) 340(1-3):73-81.
78. FABIAN WMF, TIMOFEI S: Comparative Molecular Field Analysis (CoMFA) of Dye-Fibre Affinities II: Symmetrical Bisazo Dyes. J. Mol. Struct. THEOCHEM (1996) 362(2):155-162.
79. TIMOFEI S, FABIAN WMF: Comparative molecular field analysis (CoMFA) of heterocyclic monoazo dye-fibre affinities. J. Chem. Inf. Comput. Sci. (1998) 38(6):1218-1222.
80. POLANSKI J, BAK A, GIELECIAK R, MAGDZIARZ T: Modeling robust QSAR, J. Chem. Inf. Model. (In Press).
81. http://www.chemie.tu-darmstadt.de/Fachgebi ete/PC/AKBrickmann/research/ SurfaceSeg ment.tud.
82. http://www.molecular-networks.com/, Molecular Networks GmbH.
83. http://uranos.cto.us.edu.pl/~ zchorg/